HYBRIDE AMIDDERIVATE VON AMPHOTERICIN B

Patent europeic · EP4192248 · En vigur

Inscripziun en il register

Numer da publicaziun
EP4192248
Numer da la dumonda
EP21856507
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
09-08-2021
Publitgà
14-06-2023
Concedì
03-12-2025
La protecziun finescha il pli tard
08-08-2041
Proxima taxa annuala scadenta
31-08-2027
Classas IPC
C07H 17/08 (2006.01)
A61P 31/10 (2006.01)
Prioritad
US 202063063655 P 10.08.2020
US 202163175771 P 16.04.2021
Dumonda PCT
PCT/US2021/045205 09.08.2021
Publicaziun PCT
WO2022/035752 17.02.2022
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 14-10-2026

    Midada

    Published in Swissreg on 14.10.2026

  2. 01-09-2026

    Next annual fee due on

    Next annual fee due on
    31.08.2026 → 31.08.2027

    Published in Swissreg on 01.09.2026

  3. 10-02-2026

    Represchentant inscrit

    Representative
    Stolmár & Partner Intellectual Property S.à.r.l., Bahnhofstrasse 11, 6210 Sursee

    Published in Swissreg on 10.02.2026

  4. 03-12-2025

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 03.12.2025

Partidas

Inventur

BURKE, Martin, D.

Champaign, IL 61821, US

MAJI, Arun

Champaign, IL 61820, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.